SCHEMBL26259656

SCHEMBL26259656

CC(C)(C)c1ccc2c(-c3ccco3)cccc2c1-c1ccco1

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MET P08581 1/20 0.34
▸ GLO1 Q04760 1/20 0.33
▸ CCNA2 P20248 1/20 0.33
▸ CDK2 P24941 1/20 0.33
▸ TTK P33981 1/20 0.33
▸ HTR1A P08908 2/20 0.33
▸ HTR7 P34969 2/20 0.33
▸ CFTR P13569 2/20 0.33
▸ TUBB4A P04350 2/20 0.32
▸ TUBB P07437 2/20 0.32
▸ TUBA3C P0DPH7 2/20 0.32
▸ TUBA1B P68363 2/20 0.32
▸ TUBA4A P68366 2/20 0.32
▸ TUBB4B P68371 2/20 0.32
▸ TUBB3 Q13509 2/20 0.32
▸ TUBB2A Q13885 2/20 0.32
▸ TUBB8 Q3ZCM7 2/20 0.32
▸ TUBA3E Q6PEY2 2/20 0.32
▸ TUBA1A Q71U36 2/20 0.32
▸ TUBA1C Q9BQE3 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26259680 0.90 ALDH1A1 (0.38) POLBALDH1A1TDP1L3MBTL1KDM4E
SCHEMBL26259526 0.83 CFTR (0.36) CFTRPOLBALDH1A1TDP1L3MBTL1
SCHEMBL26259346 0.79 ALDH1A1 (0.41) POLBALDH1A1TDP1L3MBTL1KDM4E
SCHEMBL26259582 0.79 BRD4 (0.37) METGLO1CCNA2CDK2TTK
SCHEMBL26259566 0.77 POLB (0.48) METGLO1CCNA2CDK2TTK
SCHEMBL26259540 0.77 IMPDH2 (0.34) CFTRALDH1A1TDP1L3MBTL1IMPDH2
SCHEMBL25667075 0.75 PLAU (0.51) CCNA2CDK2TTKTUBB4ATUBB
SCHEMBL26259367 0.75 NR1I2 (0.45) CDK2POLBALDH1A1TDP1L3MBTL1
SCHEMBL22426573 0.74 ALDH1A1 (0.43) HTR1AHTR7CFTRPOLBALDH1A1
SCHEMBL22380051 0.72 CA2 (0.35) CFTRPOLBALDH1A1TDP1L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230287262-A1 PHOTON UPCONVERSION COMPOSITION, FILM, METHOD FOR CONVERTING VISIBLE LIGHT INTO ULTRAVIOLET LIGHT, AND COMPOUND KYUSHU UNIVERSITY, NATIONAL UNIVERSITY CORPORATION (JP) 2023-09-14 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230287262-A1 PHOTON UPCONVERSION COMPOSITION, FILM, METHOD FOR CONVERTING VISIBLE LIGHT INTO ULTRAVIOLET LIGHT, AND COMPOUND NUDC, CCNL2, SPIN3 MET 4469/4885GLO1 1074/4885CCNA2 672/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback